文献速递其他结缔组织病

补体C4低拷贝数与C4A缺陷是肌炎、其亚型及自身抗体的风险因素

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies.
PubMed 文献 · Ann Rheum Dis · 2022-09-28

在1644例高加索裔特发性炎症性肌病患者与3526例匹配健康对照中,总C4低基因拷贝数(C4T=2+3)和C4A缺陷(C4A=0+1)与特发性炎症性肌病风险升高强相关;C4A缺陷者中HLA-DR3作为风险因素除包涵体肌炎外不再显著,抗Jo-1或抗PM/Scl阳性者血浆C4浓度显著低于阴性者。

要点

  • 总C4低拷贝数(C4T=2+3)与特发性炎症性肌病风险升高相关,OR=2.58(2.28-2.91)。
  • C4A缺陷(C4A=0+1)与特发性炎症性肌病风险升高相关,OR=2.82(2.48-3.21)。
  • C4A缺陷者中HLA-DR3除包涵体肌炎外不再显著;包涵体肌炎中98.2%有HLA-DR3,OR=11.02(1.44-84.4)。

核心结论

  • C4A缺陷与皮肌炎相关,HLA-DRB1*03在包涵体肌炎中重要,C4A缺陷与HLA-DRB1*03交互性贡献多发性肌炎风险。

研究设计与样本

  • 采用实时PCR或Southern印迹分析,检测1644例高加索裔特发性炎症性肌病患者与3526例匹配健康对照的总C4、C4A、C4B及长、短基因的基因拷贝数变异。
  • 血浆补体水平采用单向径向免疫扩散法测定。

主要发现

  • 总C4低拷贝数(C4T=2+3)与特发性炎症性肌病风险升高强相关,OR=2.58(2.28-2.91),p=5.0×10-53。
  • C4A缺陷(C4A=0+1)与特发性炎症性肌病风险升高强相关,OR=2.82(2.48-3.21),p=7.0×10-57。
  • 在C4A缺陷患者中,HLA-DR3作为特发性炎症性肌病风险因素除包涵体肌炎外变得不显著;包涵体肌炎患者中98.2%有HLA-DR3,OR=11.02(1.44-84.4)。
  • 抗Jo-1或抗PM/Scl阳性的特发性炎症性肌病患者血浆C4浓度显著低于无这些自身抗体的患者。

关键数值与推荐

  • 总C4低拷贝数定义为C4T=2+3,C4A缺陷定义为C4A=0+1。
  • 总C4低拷贝数与特发性炎症性肌病风险:OR=2.58(2.28-2.91),p=5.0×10-53。
  • C4A缺陷与特发性炎症性肌病风险:OR=2.82(2.48-3.21),p=7.0×10-57。
  • 包涵体肌炎中HLA-DR3的OR=11.02(1.44-84.4),98.2%患者有HLA-DR3。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases characterised by myositis-related autoantibodies plus infiltration of leucocytes into muscles and/or the skin, leading to the destruction of blood vessels and muscle fibres, chronic weakness and fatigue. While complement-mediated destruction of capillary endothelia is implicated in paediatric and adult dermatomyositis, the complex diversity of complement C4 in IIM pathology was unknown. METHODS: We elucidated the gene copy number (GCN) variations of total C4, C4A and C4B, long and short genes in 1644 Caucasian patients with IIM, plus 3526 matched healthy controls using real-time PCR or Southern blot analyses. Plasma complement levels were determined by single radial immunodiffusion. RESULTS: The large study populations helped establish the distribution patterns of various C4 GCN groups. Low GCNs of C4T (C4T=2+3) and C4A deficiency (C4A=0+1) were strongly correlated with increased risk of IIM with OR equalled to 2.58 (2.28-2.91), p=5.0×10-53 for C4T, and 2.82 (2.48-3.21), p=7.0×10-57 for C4A deficiency. Contingency and regression analyses showed that among patients with C4A deficiency, the presence of HLA-DR3 became insignificant as a risk factor in IIM except for inclusion body myositis (IBM), by which 98.2% had HLA-DR3 with an OR of 11.02 (1.44-84.4). Intragroup analyses of patients with IIM for C4 protein levels and IIM-related autoantibodies showed that those with anti-Jo-1 or with anti-PM/Scl had significantly lower C4 plasma concentrations than those without these autoantibodies. CONCLUSIONS: C4A deficiency is relevant in dermatomyositis, HLA-DRB1*03 is important in IBM and both C4A deficiency and HLA-DRB1*03 contribute interactively to risk of polymyositis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Zhou D, King EH, Rothwell S, et al. Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies. Ann Rheum Dis. 2022. PMID: 36171069. doi:10.1136/ard-2022-222935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。